Transplant diagnostics methods are widely used to diagnose the compatibility of the replaced organs or the transplantation organs. The market is valued at $3.26 billion in 2017 and is anticipated to reach $4.95 billion by 2024, with CAGR of 7.6%. The factors such as increasing number of the transplant procedure, the growing burden of infectious diseases, increasing public-private funding for target research activities and technological advancements in the field of transplant diagnostics are driving the market growth. High procedural cost of NGS and PCR-based diagnostic assays, procedural and technical limitations associated with donor-recipient screening, a significant gap between the number of organ donors and organs required annually and limited reimbursements for target procedures are restricting the market growth.

Research Study Objectives:

• Define, estimate, and forecast the Transplant Diagnostics market statistics by product and services, technology, type of screening, transplant type, application, end-user and regions concerning the individual growth drivers, market trends and their contribution toward the Transplant Diagnostics market growth
• Provides comprehensive information regarding the key factors influencing the market growth (Drivers, Restraints & Challenges, and Opportunities)
• Estimate & forecast the market size of all the segments concerning geographies including North America, Europe, Asia Pacific (APAC), South America and the Middle East and Africa (MEA).
• Recent competitive developments including M&A (Mergers and Acquisitions), Partnerships, and Product Innovations are provided in the Transplant Diagnostics Market Analysis
• Analysis and conclusions on the future Transplant Diagnostics market outlook.

Top-down and bottom-up approaches are used to validate the Transplant Diagnostics Market Size and are used to estimate the size of other dependent submarkets. Key players in the market are identified through various secondary sources; databases including Bloomberg Businessweek, Hoovers, Factiva, journals and associations and the market revenues are estimated and are thoroughly validated through primary and secondary research. Secondary research involves the study of annual and financial reports of top players in the market, whereas primary research includes extensive interviews with the KoL’s such as CEOs, directors, board members, VP’s, sales managers, engineers, marketing executives, technicians, account managers, investors, strategic decision makers and others. The Transplant Diagnostics Market shares and breakdowns are determined using secondary sources and are verified by the primary sources. All possible parameters/factors that are affecting the Transplant Diagnostics market demand are covered in the research study are verified through primary research, analysed and interpreted to get the final qualitative and quantitative data. This data is collected and added with detailed analysis from Envision Inteligence and presented in this report.

The scope of the Report

The Transplant Diagnostics market segmentation is as follows:

By Product and services

• Reagents and Consumables
• Instruments
• Software and Services

By Technology

• Molecular Essays
  • PCR-Based Molecular Assay
  • Real-Time PCR
  • Sequence-Specific Primer-PCR
  • Sequence-Specific Oligonucleotide-PCR
  • Others
• Sequencing-Based Molecular Assays
  • Sanger Sequencing
  • Next-Generation Sequencing
  • Others
• Non-Molecular Assays

By Type of screening

• Pre-transplant Screening
• Post-transplant screening

By Transplant type

• Solid Organ Transplantation
  • Kidney Transplantation
  • Liver Transplantation
  • Heart Transplantation
  • Lung Transplantation
  • Pancreas Transplantation
  • Others
• Stem Cell Transplantation
• Soft Tissue Transplantation

By Application

• Diagnostic Applications
  • Pre-Transplantation Diagnostics
• Infectious Disease Testing
• Histocompatibility Testing
• Blood Profiling
  • Post-Transplantation Diagnostics
• Research Applications

By End-user

• Independent Reference Laboratories
• Hospitals & Transplant Centers
• Research Laboratories & Academic Institute

Geographical Analysis:

Transplant Diagnostics Market is segmented by geography into North America, South America, Europe, APAC and Middle East & Africa. U.S., Canada, Mexico and Costa Rica are analysed under North American region which is usually turning as the hotspot in the market. The South American region is further segregated into Brazil, Argentina, Chile, Columbia and some other emerging economies. In Europe, the market is extensively examined by covering U.K., Germany, France, Italy, Spain, Netherlands, Poland, Switzerland and some other promising economies. APAC is further categorised by countries into China, India, Japan, South Korea, Australia & New Zealand, Malaysia, Singapore and many other emerging nations. In the Middle East & African region, Saudi Arabia, UAE, Iran, Iraq, Qatar, South Africa, Algeria, Morocco, Nigeria and so on countries are evaluated to understand the market growth lucidly.

Customization Options:

With the given research report, Envision Inteligence offers customisations as per the client’s specific requirements. The following customisation options offered for the Transplant Diagnostics Market include:

• Scope Revision
• Geographic Analysis
• Company Profiles
• Historical Data & Forecasting
• Key Contact Persons in companies

Global Transplant Diagnostics Market Research Report Includes:

• An executive summary condensing the whole report such that essential authority can rapidly twist up doubtlessly acquainted with brief overview and conclusion.
• To have a complete market analysis through industry value chain analysis, Porter’s Five Force Model, PESTLE, SWOTanalysis, and Y-o-Y analysis.
• Regional and global diversity is analysed with the major countries and the unions. Scrutinizing the revenue generation on Year–On–Year
• Identifying DROC in the current market and their impact on altering market dynamics.
• Competitive landscape analysis to identify the merger and acquisition which will have a comparative financial study with significant competitors.
• Expertise investment opportunities by an analyst to the individual and organisation to have a better foothold in the market.
• Identify the latest developments, market shares and strategies that are employed by the significant Transplant Diagnostics market players, such as
  • Becton, Dickinson and Company
  • Biofortuna Ltd.
  • Biomérieux SA
  • Bio-Rad Laboratories
  • Caredx Inc.
• Along with these companies, many other companies are considered in the report while analysing the Global Transplant Diagnostics market competitive strategies and environment. These companies held substantial share-owning to the nature of the industry whereas, the rest of the market shares are marginal chunks to regional and local level manufacturers. Other players also have considerable presence owing to its robust brand image, geographical reach and stable customer base.